ClinicalTrials HQ

Darolutamide + Consolidation Radiotherapy in Advanced Prostate Cancer Detected by PSMA

Darolutamide + Consolidation Radiotherapy in Advanced Prostate Cancer Detected by PSMA

Active, not recruiting · NCT04319783 · Registry updated 2025-08-21
Ask about research services

Clinical trials

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Darolutamide + Consolidation Radiotherapy in Advanced Prostate Cancer Detected by PSMAGenital Diseases, Male Urogenital Diseases, Neoplasms by Site, Urogenital Diseases, Urogenital Neoplasms, male reproductive organ cancer, male reproductive system disorder, neoplasm, prostate cancer, prostate disorderActive, not recruitingPhase 22025-08-21NCT04319783

3 results · Page 1 of 1

Organizations

Swipe the table sideways for more columns.

OrganizationsLinked trials
Bayer178
Peter MacCallum Cancer Centre, Australia48
Trans Tasman Radiation Oncology Group9

16 results · Page 1 of 1

Research sites

Swipe the table sideways for more columns.

Research sitesCityCountryLinked trials
Calvary Mater NewcastleWaratahAustralia49
GenesisCare Fiona Stanley HospitalMurdochAustralia1
GenesisCare HurstvilleHurstvilleAustralia2
GenesisCare North ShoreSaint LeonardsAustralia1
Icon Cancer Centre EpworthRichmondAustralia1
National Cancer Centre SingaporeSingaporeSingapore61
Peter MacCallum Cancer Centre, BendigoBendigoAustralia1
Peter MacCallum Cancer Centre, Box HillBox HillAustralia1
Peter MacCallum Cancer Centre, ParkvilleMelbourneAustralia1
Princess Alexandra Hospital (ROPAIR)WoolloongabbaAustralia1
Princess Alexandra Hospital (ROPART)Raymond TerraceAustralia1
Royal Adelaide HospitalAdelaideAustralia132
Royal Brisbane and Women's HospitalHerstonAustralia12
Royal Hobart HospitalHobartAustralia44
St Vincent's HospitalDarlinghurstAustralia1
Western HealthSt AlbansAustralia3